Recent News

• 04.03.2025 - Greenwich LifeSciences Provides Global Update on FLAMINGO-01
• 04.02.2025 - Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
• 03.27.2025 - Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
• 03.17.2025 - Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
• 02.10.2025 - Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
• 01.29.2025 - Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
• 01.27.2025 - Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
• 01.27.2025 - Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
• 01.23.2025 - Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
• 01.23.2025 - Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

Recent Filings

• 03.31.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 01.13.2025 - 4 Statement of changes in beneficial ownership of securities